Transactional Content Management

PRODUCTS

  • Technology solutions for life sciences that get products to market quickly and efficiently.

  • Siegfried is an expert in manufacturing capsule-based dry powder inhalation products.

  • Discover high-performance RF cables and adapters up to 40 GHz. These products feature customized options, rugged construction, and a three-year warranty, ensuring reliability for your testing needs.

  • Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.

  • Predict Genotoxic & Carcinogenic Endpoints to Meet ICH M7(R2) Guidelines

    ACD/Impurity Profiling Suite predicts a variety of toxicological endpoints to help you assess the genotoxic and carcinogenic potential of impurities and degradants. Developed through a collaborative agreement with the US Food and Drug Administration (FDA), the software can be used as part of your ICH M7(R2) workflow—to help prepare regulatory submissions and remain compliant.

    • Determine the ICH M7(R2) classification for impurities and degradants
    • Predict 21 toxicological endpoints from structure; for mechanisms of hazardous activity including:
      • Mutagenicity (AMES test and other procaryote and eucaryote test systems)
      • Clastogenicity
      • Other DNA damage
      • Carcinogenicity
      • Endocrine disruption mechanisms
    • Identify potentially hazardous structural fragments responsible for carcinogenic and genotoxic activity
    • Gain insight into the possible mechanisms of toxic effects
    • Assess the reliability of predictions

WHITE PAPERS AND CASE STUDIES

NEWS